secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2026-07-29T20:15:14+00:00
Accession:  0001493152-26-035193
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Celularity receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until Jan 19, 2027
--------------------------------------------------------------------------------

- Received Nasdaq notice on July 23, 2026, for non-compliance with minimum bid price rule (closing bid below $1.00 for 30 consecutive business days).
- Has 180 calendar days, until January 19, 2027, to regain compliance by closing bid price >= $1.00 for at least 10 consecutive business days.
- If not compliant by Jan 19, 2027, may be eligible for additional 180-day grace period if meeting other initial listing standards.
- Company intends to monitor bid price and evaluate options, but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000149315226035193/0001493152-26-035193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000149315226035193/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer